RSV vaccine, preF A-preF B, recombinant
Abrysvo is Formulary, Restricted to outpatient use for maternal immunization in pregnant individuals 32-36 weeks gestation.
See Arexvy and mRESVIA for formulary status of other RSV vaccines.
Abrysvo is Formulary, Restricted to outpatient use for maternal immunization in pregnant individuals 32-36 weeks gestation.
See Arexvy and mRESVIA for formulary status of other RSV vaccines.